Milrinone 10mg/10ml concentrate for solution for infusion ampoules Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

milrinone 10mg/10ml concentrate for solution for infusion ampoules

stragen uk ltd - milrinone - solution for infusion - 1mg/1ml

Milrinone BOS Solution for injection Saúdská Arábie - angličtina - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

milrinone bos solution for injection

boston oncology arabia, saudi arabia - milrinone - solution for injection - 1 mg/ml

Milrinone 10mg/10ml solution for infusion ampoules Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

milrinone 10mg/10ml solution for infusion ampoules

macure pharma uk ltd - milrinone - solution for infusion - 1mg/1ml

Milrinone 10mg/10ml solution for injection vials Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

milrinone 10mg/10ml solution for injection vials

tillomed laboratories ltd - milrinone lactate - solution for injection - 1mg/1ml

Milrinone Stragen 1 mg/ml inf. sol. (conc.) i.v. amp. Belgie - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

milrinone stragen 1 mg/ml inf. sol. (conc.) i.v. amp.

stragen nordic a.s. - milrinone 1 mg/ml - concentrate for solution for infusion - milrinone

Milrinone Stragen 1 mg/ml inf. sol. (conc.) i.v. amp. Belgie - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

milrinone stragen 1 mg/ml inf. sol. (conc.) i.v. amp.

stragen nordic a.s. - milrinone 1 mg/ml - concentrate for solution for infusion - milrinone

MILRINONE Injection 10mg "TAKATA" (ミルリノン注10mg「タカタ」) Japonsko - angličtina - すりの適正使用協議会 RAD-AR Council, Japan

milrinone injection 10mg "takata" (ミルリノン注10mg「タカタ」)

takata pharmaceutical co., ltd. - milrinone - injection

PRIMACOR INJECTION Izrael - angličtina - Ministry of Health

primacor injection

sanofi israel ltd - milrinone - solution for injection - milrinone 1 mg/ml - milrinone - milrinone - for the treatment of refractory heart failure immediately (up to 72 hours) following cardiac surgery. for the short term ( up to 48 hours) intravenous therapy of severe refractory congestive heart failure.in pediatric population primacor is indicated for the short-term treatment (up to 35 hours) of severe congestive heart failure unresponsive to conventional maintenance therapy (glycosides, diuretics, vasodilators and/or angiotensin converting enzyme (ace) inhibitors), and for the short-term treatment (up to 35 hours) of pediatric patients with acute heart failure, including low output states following cardiac surgery.

Primacor Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

primacor

sanofi-aventis new zealand limited - milrinone 1.43 mg/ml (as lactate. equivalent to 1mg/ml milrinone) - solution for injection - 1 mg/ml - active: milrinone 1.43 mg/ml (as lactate. equivalent to 1mg/ml milrinone) excipient: glucose monohydrate lactic acid sodium hydroxide water for injection - primacor injection is indicated for the short term intravenous therapy of severe congestive heart failure. the majority of experience with intravenous primacor has been in patients receiving digoxin and diuretics. primacor is also indicated for low output states following cardiac surgery, including weaning from cardio-pulmonary bypass pump.

Corotrope 10 mg/10 ml inf. sol. i.v. amp. Belgie - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

corotrope 10 mg/10 ml inf. sol. i.v. amp.

sanofi belgium sa-nv - milrinone 10 mg/10 ml - solution for infusion - 1 mg/ml - milrinone 10 mg - milrinone